This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Baratta, L. Articles by Rossi-Fanelli, F. Search for Related Content PubMed PubMed Citation Articles by Baratta, L. Articles by Rossi-Fanelli, F. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Cardiomyopathy Eosinophilic Disorders Social Bookmarking                   What's this?

Favorable Response to High-Dose Interferon-Alpha in Idiopathic Hypereosinophilic Syndrome with Restrictive Cardiomyopathy

Case Report and Literature Review

Antonella Afeltra, MD

Massimo Delfino, MD

Stefano De Castro, MD

Flavia Giorgino, MD

Filippo Rossi-Fanelli, MD

The idiopathic hypereosinophilic syndrome is characterized by a prolonged overproduction of eosinophils of unknown cause in addition to specific organ damage due to eosinophil-derivated protein toxicity. Its prognosis is correlated with heart involvement that results in a restrictive cardiomyopathy. This is frequently biventricular. Isolated left ventricular infiltration has rarely been reported. The authors report a case of idiopathic hypereosinophilic syndrome with cardiac involvement obliterating the left ventricular cavity with a favorable clinical outcome following a combination therapy with interferon-alpha, hydroxyurea and prednisone. Data from other studies dealing with the treatment of idiopathic hypereosinophilic syndrome with interferon- alpha are reviewed and discussed.

Angiology, Vol. 53, No. 4, 465-470 (2002)
DOI: 10.1177/000331970205300414


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?